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Abstract
Chromatin architecture has been implicated in cell-type-specific gene regulatory programs; yet, 
how chromatin remodels during development remains to be fully elucidated. Here, by 
interrogating chromatin reorganization during human pluripotent stem cell (PSC) differentiation, 
we discover a role for the primate-specific endogenous retrotransposon HERV-H in creating 
topologically associating domains (TAD) in human PSCs. Deleting these HERV-H elements 
eliminates their corresponding TAD boundaries and reduces transcription of upstream genes, while 
de novo insertion of HERV-Hs can introduce new TAD boundaries. HERV-H’s ability to create 
these TAD boundaries depends on high transcription, as transcriptional repression of HERV-H 
elements prevents formation of these boundaries. This ability is not limited to human PSCs, as 
these actively transcribed HERV-Hs and their corresponding TAD boundaries also appear in PSCs 
from other hominids but not in more distantly related species lacking HERV-Hs. Overall, our 
results provide direct evidence for retrotransposons in actively shaping cell-type- and species-
specific chromatin architecture.
Introduction
The three-dimensional organization of chromosomes enables long-range interactions 
between enhancers and promoters that are critical for building complex gene regulatory 
networks in multicellular species1,2. In somatic cells, interphase chromosomes occupy 
separate nuclear spaces known as chromosome territories3. Each chromosome is organized 
into a dynamic but non-random hierarchical structure characterized by stretches of 
transcriptionally active, megabase-long compartments that are interspersed with stretches of 
transcriptionally inactive compartments4. These compartments can be further partitioned 
into topologically associating domains (TADs), which exhibit high levels of intra-domain 
interactions and relatively low levels of inter-domain interactions5–7. TAD boundaries are 
generally conserved between cell types and closely related species5,8, and can restrict cis-
regulatory element interactions with target promoters9. At or within TAD boundaries, long-
range chromatin loops are frequently observed to link regulatory elements, including binding 
sites for the CCCTC-binding factor (CTCF), promoters and enhancers10,11. Thus, disrupting 
TADs can lead to failure of proper restructuring of chromatin and subsequent changes of 
transcriptional landscape that may eventually lead to disease12–15.
There is mounting evidence that a large fraction of TADs are shaped by CTCF, which 
occupies a majority of the TAD boundaries, and by the cohesin complex that generally 
colocalizes with CTCF16–20. The evolution and turnover of CTCF binding sites have been 
suggested to underlie the evolution of genome architecture in different species21, since a 
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subset of species-specific CTCF binding sequences are rapidly dispersed by transposable 
elements, in particular SINE elements22. However, how much transposable elements play a 
role in shaping the genome architecture during evolution has yet to be directly tested, 
particularly in primates.
Genome architecture is not only reshaped during evolution, but also reconfigured in a cell-
type-specific manner during differentiation and somatic cell reprogramming8,23–26. By 
interrogating the dynamic remodeling of chromatin architecture during human 
cardiomyocyte differentiation, we discover a class of primate-specific endogenous 
retrotransposons, human endogenous retrovirus subfamily H (HERV-H), which is involved 
in establishing TAD boundaries in hPSCs. Deletion of these HERV-H elements eliminates 
corresponding TAD boundaries, while de novo insertion of HERV-Hs can introduce new 
chromatin domain boundaries in human PSCs. These TAD boundaries are furthermore 
highly dependent on HERV-H transcription, as transcriptional silencing of HERV-Hs during 
hPSC differentiation or by genetic manipulation weakens or eliminates the insulation of 
TAD boundaries. Finally, comparative analysis of chromatin architecture in primate and 
non-primate species supports a role for actively transcribed HERV-Hs in demarcating 
primarily hominid PSC-specific TADs. Overall, our results provide direct evidence for 
retrotransposon elements in actively shaping chromatin architecture in specific cell types 
during evolution.
Results
Chromatin architecture undergoes reorganization during differentiation
To characterize the dynamics of genome organization during differentiation, we utilized a 
transgenic human embryonic stem cell (hESC) H9 MYL2:H2B-GFP ventricular 
cardiomyocyte reporter line, which can be differentiated into ventricular cardiomyocytes in a 
highly synchronized fashion27 (Supplementary Fig. 1a). We generated and collected samples 
in biological duplicates at six critical time points of cardiomyocyte differentiation: hESCs 
(Day 0), mesodermal cells (Day 2), cardiac mesodermal cells (Day 5), cardiac progenitors 
(Day 7), primitive cardiomyocytes (Day 15) and ventricular cardiomyocytes (Day 80) (Fig. 
1a). Flow cytometry confirmed that differentiation efficiency for D2 – D15 time point 
samples was at least ~80-90%, and MYL2:H2B-GFP+ ventricular cardiomyocytes were 
sorted at day 80 (Supplementary Fig. 1b). We performed in situ Hi-C4 experiments, and 
obtained on average three billion raw read pairs and one billion unique long-range cis 
contacts (minimum distance 10 kb, Supplementary Table 1) for each time point. Close 
correlation of Hi-C maps between biological replicates verified that these maps were highly 
reproducible at multiple scales (Supplementary Fig. 2a–d). Complementing these Hi-C 
contact maps, ChIP-seq and RNA-seq experiments were performed on these samples to 
identify CTCF and H3K27ac occupancy sites, and profile transcriptomes, respectively 
(Supplementary Fig. 2e–i).
Analyses of these Hi-C datasets showed extensive reorganization of chromatin architecture 
during hESC differentiation (Fig. 1a). Across the entire genome, the abundance of short-
range chromatin interactions decreased while the number of long-range chromatin 
interactions (above 500 kb) increased (Supplementary Fig. 3a). Identification of active (A) 
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and inactive (B) compartments at all stages showed that 81.6% of the genome maintained 
the same compartment state throughout cardiomyocyte differentiation (Fig. 1b). Among the 
18.4% of the genome that switched compartments, a similar proportion of the genome 
switched from A to B and from B to A at each stage transition (Supplementary Fig. 3b), and 
the majority (73%) only switched once, suggesting linear nuclear architectural changes 
during lineage commitment (Fig. 1b). Hierarchical clustering of genomic bins that switched 
compartments showed stage specific dynamics (Fig. 1b), which positively correlated with 
gene expression (Supplementary Fig. 3c,d) as reported previously8.
Consistent with recent reports describing loss of TADs during ESC differentiation23,28, we 
also observed that the number of TADs decreased as hESCs differentiated into ventricular 
cardiomyocytes using multiple TAD-calling algorithms5,10,29 (Supplementary Fig. 4a, b, c). 
Clustering of stage-specific TAD boundaries using differential Directionality Index (DI) 
scores, which estimate the strength of the TAD boundaries, further showed that the majority 
of stage-specific TAD boundaries were lost or weakened during differentiation and the effect 
was most pronounced at early mesoderm specification (D0-D2), and ventricular 
cardiomyocyte differentiation/maturation (D15-D80) (Fig. 1c).
HERV-H silencing is associated with loss of TAD boundaries during differentiation
To investigate the mechanism of TAD boundary turnover, we examined the sequence 
features of TAD boundaries that were lost in the course of differentiation with a particular 
focus on D0 hESC-specific TAD boundaries [ESC(+)] and the boundaries lost during D15-
D80 ventricular cardiomyocyte transition [vCM(−)] (Supplementary Table 2). While CTCF 
has been shown to play a critical role in defining TAD boundaries5,10,20, we observed no 
significant difference in CTCF occupancy across all stages examined at ESC(+), vCM(−) 
and stable TAD boundaries (Supplementary Fig. 4d). Thus, we explored whether other 
potential mechanisms might be involved in the formation of these TAD boundaries. 
Interestingly, we discovered that eight classes of repeat elements were over-represented 
specifically at ESC(+) TAD boundaries when compared to stable TAD boundaries (P value < 
0.01 and fold change > 2), whereas no enrichment of these repeats was observed in vCM(−) 
TAD boundaries (Fig. 1d). Additionally, the ESC(+) TAD boundaries were associated with 
hESC-specific H3K27ac signal and mRNA transcription (Supplementary Fig. 4e, f), which 
was particularly enriched for HERV-H transcription (Fig. 2a and Supplementary Fig. 5a).
HERV-H is a class of primate-specific endogenous retrotransposons. It is transcriptionally 
active in both human preimplantation embryos and PSCs30,31, and plays a critical role in 
pluripotency, stem cell maintenance and somatic cell reprograming32–36. Although more 
than 1,000 copies of HERV-H sequences exist in the human genome, they are expressed at 
different levels in hESCs (Fig. 2b)32. Notably, we discovered that the top 50 highly 
transcribed HERV-H loci are predominantly located at TAD boundaries in hESCs (Fig. 2c, 
Supplementary Fig. 5b) and that these TAD boundaries are lost when HERV-Hs are 
transcriptionally silenced in hESCs differentiating into mesodermal cells at day 2 (Fig. 2d; 
specific loci in Fig. 2e, f and Supplementary Fig. 5c, d, e). In addition, we found HERV-H-
associated TAD boundaries were not only present in H9 hESCs but also other hPSCs 
including H1 hESCs8,37 and human induced PSCs (iPSCs)38. However, similar to our H9 
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hESC data, these PSCs when differentiated into other lineages did not appear to exhibit 
HERV-H expression and associated TAD boundaries (Supplementary Fig. 6a). Given these 
findings, we further tested whether this correlation of TAD boundary and transcription is 
unique to HERV-H, or if high transcriptional activity in general correlate with boundary 
strength. We ranked all genes by their expression levels from high to low in hESCs, grouped 
every 1,000 genes into a bin, separated bins into two categories based on whether they 
contain CTCF peaks near their promoters, and then examined the DI scores at these 
corresponding promoters. We found that highly transcribed genes without CTCF peaks in 
their promoters displayed slightly higher boundary strength than lowly transcribed genes; 
however, the boundary strength was substantially lower than those observed in HERV-Hs 
with comparable expression levels (Supplementary Fig. 6b). Furthermore, additional 
genome-wide analyses revealed two genomic loci that contain a solo LTR7 sequence 
(HERV-H promoter), thus suggesting that HERV-H internal sequence or RNA may not be 
required in TAD formation (Supplementary Fig. 7). Taken together, these findings suggest 
that the HERV-H promoter may have a special sequence composition or transcription 
frequency that contributes to TAD boundary formation.
To explore how HERV-Hs might contribute to TAD boundary formation, we examined 
publicly available ChIP-seq data of histone modifications and transcription factors (TFs) in 
hESCs. Consistent with previous observations34, we found that not only RNA polymerase II 
subunit A (POLR2A) but also several histone modifications and transcription factors were 
enriched at sites for the top 50 transcribed HERV-Hs. Unexpectedly, three subunits of the 
cohesin complex were also enriched at these HERV-H elements (Supplementary Fig. 8). To 
further investigate the role of cohesin in HERV-H-mediated TAD boundary formation, we 
performed ChIP-seq in hESCs for the cohesin complex subunit SMC3. Analyzing this ChIP-
seq data along with RNA-seq as well as CTCF and POLR2A ChIP-seq data, we observed 
broad enrichment of cohesin, CTCF and POLR2A specifically at the 3’ end of these highly 
transcribed HERV-H sequences (Fig. 2g). The enrichment of these factors was not observed 
at sites of less active HERV-Hs (Fig. 2g), suggesting that they might play a role in mediating 
the formation of TAD boundaries by HERV-Hs. Interestingly, weak but reproducible broad 
enrichment of CTCF binding signal was observed in these regions despite the absence of 
canonical CTCF binding motifs (Fig. 2g), raising the possibility that CTCF may assist in 
defining these HERV-H-associated TAD boundaries as it does in most other TAD 
boundaries. Overall, these data support that HERV-Hs form TAD boundaries by 
accumulating cohesin complexes at its 3’ end, likely positioned by the transcribing POL2 
complex39,40.
Deletion of HERV-H elements abolishes nearby TAD boundaries and changes gene 
expression
To determine the role of HERV-H sequences in TAD boundary formation in hESCs, we 
produced two genetically engineered hESC lines, termed as HERV-H1-KO and HERV-H2-
KO respectively, in which two HERV-H elements located at two of the strongest hESC TAD 
boundaries were deleted using CRISPR-Cas9 genome editing tools. In both cases, deletion 
of HERV-H resulted in elimination of TAD boundaries, as evidenced by merging of the two 
TADs bordering each HERV-H element (Fig. 3a). Furthermore, deletion of HERV-H resulted 
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in reduced expression of genes in the TAD domain immediately 5’ upstream of the HERV-H 
sequence (Fig. 3a). These findings demonstrated that HERV-H sequences are indispensable 
for the TAD boundaries formed at these regions, and moreover that the presence of HERV-H 
increases the transcriptional activity of the neighboring genes in the same TAD domain, 
supporting the notion that HERV-Hs may serve as enhancers in hESCs41,42. Notably, this 
activating effect is only seen in the genes on the 5’ end of HERV-H and not the 3’ end, 
suggesting that boundaries present on the 3’ end of HERV-Hs, may insulate the effect of 
enhancers. Supporting this possibility, additional analyses showed that genes located within 
500 kb or within the TADs upstream of boundary-associated HERV-Hs were more likely to 
be up-regulated in hESCs compared to differentiated cells than genes in the downstream 
(Fig. 3b and Supplementary Fig. 9a), respectively.
Further examination of the transcriptional profiles of both HERV-H knockout cell lines 
revealed that expression of 353 and 144 genes were significantly changed (Supplementary 
Fig. 9b, c, Supplementary Table 3), and alterations of gene expression profiles in HERV-H1-
KO and HERV-H2-KO were highly concordant (Supplementary Fig. 9d, Pearson r = 0.5, P 
value< 1 × 10−15) despite both engineered cells maintaining pluripotency. Of the 43 genes 
down-regulated in both KOs, 10 (23%) were located within 20 kb of other HERV-H 
sequences (Supplementary Fig. 9e), including two well-studied chimeric transcripts 
SCGB3A243 and LINC0045844, which are known to be regulated by HERV-Hs 
(Supplementary Fig. 9f, g). Thus, these data suggest that deletion of individual HERV-H 
sequences could lead to down-regulation of HERV-H-related transcription at other loci.
In further analyzing genes differentially expressed in our HERV-H knockout lines, we 
discovered that the human-specific long-coding RNA (lncRNA), Heart Brake (HBL1), 
which has been reported recently to suppress cardiomyocyte differentiation45, was also 
significantly reduced in the HERV-H1-KO hESCs (Supplementary Fig. 9g). Thus, we 
hypothesized that these changes in transcriptional landscape in the HERV-H1-KO could 
promote cardiomyocyte differentiation. To test this hypothesis, we examined the 
cardiomyocyte differentiation efficiency of HERV-H1-KO hESCs compared to control 
hESCs under suboptimal cardiomyocyte differentiation conditions. While these conditions 
led to ~40% cardiomyocyte differentiation efficiency at day 15 in control hESCs, we 
discovered that HERV-H1-KO hESCs exhibited > 80% cardiomyocyte differentiation 
efficiency (Fig. 3c). Thus, our results suggest that removal of highly expressed TAD-
associated HERV-Hs may alter the potential of hESCs to exit pluripotency and are consistent 
with recent work reporting that hyper-activation of some HERV-H LTR7s prevents hPSC 
lines from effectively differentiating into neuronal cells46.
Transcriptional repression removes HERV-H-driven TAD boundaries
Having established that HERV-H DNA sequences are required for TAD boundary formation, 
we investigated whether its transcriptional activity is also essential. To address this question, 
we blocked the transcription of the aforementioned HERV-H loci by employing a CRISPR-
dCas9-KRAB system with sgRNAs that targeted the promoters (5’ LTR7) of these HERV-Hs 
(Fig. 4a). Each sgRNA specifically reduced the targeted HERV-H expression by over 70% 
(Fig. 4b). Accompanying the reduction of HERV-H, the TAD boundary was weakened, as 
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evidenced by the decreased directionality index (Fig. 4c). This result indicates that HERV-
H’s high transcriptional activity is required for creating TAD boundaries in hESCs. 
Consistent with the HERV-H KO data, the genes 5’ upstream of HERV-Hs were also down 
regulated when HERV-H transcription was repressed (Fig. 4c). In addition, all 10 down-
regulated HERV-H loci in HERV-H KO hESCs showed down-regulation in both these lines, 
suggesting that modulation of individual HERV-H sequences or transcription might impact 
HERV-H transcription at other loci. However, trans-interactions between active HERV-Hs 
were not observed (Supplementary Fig. 10), suggesting such regulation might be achieved 
through mechanisms yet to be characterized.
de novo HERV-H insertion creates new TAD boundaries in hPSCs
To investigate whether HERV-Hs can create TAD boundaries de novo, we engineered two 
human hESC lines in which an 8-kb sequence from the HERV-H2 locus (which includes 1 
kb of additional sequences flanking of HERV-H2) was randomly inserted into multiple 
locations in the HERV-H2-KO hESC genome using a piggybac transposon (Fig. 5a). The 
exact location of 43 HERV-H2 inserts was determined by a combination of proximity 
location analysis using Hi-C and chimeric transcripts analysis using RNA-seq, as HERV-Hs 
frequently form chimeric transcripts and/or exhibit extensive read-through beyond the 3’ 
LTR (Supplementary Fig. 11c, Supplementary Table. 4). Out of these 43 insertions, 16 
exhibited a significant increase in the local contact insulation at the place of insertion, as 
evidenced by the change in Hi-C contact matrix and DI score (Fig. 5b). Furthermore, out of 
these 16 insertions, the allele harboring the HERV-H insertion could be unambiguously 
identified in 15 cases, where insertion of HERV-H was accompanied with allele-specific 
increase in insulation (Fig. 5c, d). Thus, these results indicate that HERV-H insertions can 
create chromatin boundaries de novo. However, at some places of insertion, the HERV-Hs 
might be silenced by the genomic contexts, thus no longer capable of forming TAD 
boundaries. As we showed earlier, 70% reduction of HERV-H transcription is sufficient to 
remove its associated TAD boundaries (Fig. 4b,c).
HERV-H introduces new TAD boundaries during primate evolution
It is estimated that HERV-H integrated into the primate lineage 30-40 million years ago 
(MYA) at the time of divergence of Old and New World monkeys47,48, with the largest 
expansion (LTR7 and LTR7B) occurring in the Old World monkey lineage, including 
hominids47. Consequently, hominids, including humans, harbor over 1,000 copies of HERV-
Hs, whereas New World monkeys only have 50-100 copies in their genomes. To explore 
whether HERV-Hs might have introduced de novo chromatin domains during primate 
evolution, we performed Hi-C to interrogate the chromatin architecture in iPSCs from 
bonobo, chimpanzee and marmoset (New World monkey). To complement these studies, we 
also examined Hi-C data of mouse ESC23 as a non-primate control. As we had expected 
because of their evolutionary distance to humans, TAD boundaries also exist in bonobo and 
chimpanzee iPSCs in the regions syntenic to the top 50 transcribing HERV-H loci in hESCs, 
which harbor similar HERV-Hs; whereas marmoset iPSCs and mouse ESCs do not contain 
HERV-Hs nor exhibit insulation at these syntenic regions (Fig. 6a,b and Supplementary Fig 
12a). Taken together, our data suggest that HERV-H introduced de novo TAD boundaries 
during primate evolution in a transcription-dependent manner. Consistent with this notion, 
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additional sequence analysis of the HERV-H LTR sequence showed that the TAD-forming 
HERV-Hs were predominantly flanked by a 450 bp subtype of LTR7 at both ends 
(Supplementary Fig. 12b,c), which display less sequence divergence between their 5’ LTRs 
and 3’ LTRs (Supplementary Fig. 12d), thus suggesting that these HERV-Hs likely were 
inserted more recently than other HERV-Hs that do not form TAD boundaries, or were 
impacted by gene conversion or selection49.
Discussion
Evolution of multicellular organisms is driven, in large part, by the invention of new gene 
regulatory circuits responsible for the fitness traits of each species. A long-standing theory 
holds that retroviruses may play an important role in the evolution of gene regulatory 
logic50,51. Over the years, many classes of endogenous retroviral elements have been found 
to recruit transcription factors to regulate nearby genes in a cell-type-specific manner, or 
initiate transcription of non-coding RNAs with regulatory functions41,52. Importantly, the 
expansion of SINE elements in rodents, dogs and opossums has been attributed to the 
rewiring of gene regulatory networks in these mammals by expanding, in each species, the 
repertoires of CTCF22, a DNA binding protein with a critical role in chromatin organization. 
Surprisingly, no evidence has been found so far for repeat-driven expansion of CTCF 
binding in primate genomes22, raising the question whether retrotransposon-driven 
chromatin re-organization indeed is a general strategy of evolution that applies also to the 
primate lineage.
Here, we provide multiple lines of evidence demonstrating that the primate-specific HERV-
H retroviral elements can delineate TAD boundaries in the human PSCs. Previous studies 
suggested that HERV-Hs integrated into the human genome during primate evolution to 
regulate human-specific pluripotency by creating novel chimeric transcripts (ESRG32, linc-
ROR36,53 and LINC0045844) and providing potential binding sites to recruit pluripotency 
factors (NANOG, SOX2 and POU5F1)33. However, our findings indicate that HERV-H 
sequences may affect gene regulatory programs by also creating new hPSC-specific TAD 
boundaries that shape chromatin architecture. Although the cohesin complex is involved in 
forming long-range chromatin loops at CTCF binding sites16,17 and most TAD boundaries 
are occupied by CTCF and cohesin complex in mammalian cells, these HERV-H-associated 
TAD boundaries appear to lack canonical CTCF binding motifs and sharp CTCF ChIP-seq 
peaks despite retaining cohesin complexes. From our CRISPRi and ChIP-seq studies, we 
discovered that HERV-H’s ability to form TAD boundaries is highly dependent on 
transcription and more specifically RNA Polymerase II (rather than CTCF) possibly 
positioning cohesin complexes (Supplementary Fig. 13). This finding is consistent with 
recent reports on the role of transcription and polymerase movement in positioning cohesin 
complexes to create insulation and reshape chromatin structure39,40. Furthermore, this 
HERV-H-mediated TAD-boundary forming process appears to potentially affect the 
regulation of gene transcription upstream but not downstream of the HERV-H loci, thus 
providing insight as to how HERV-Hs may impact gene regulatory networks. However, 
whether this observation is a general rule for all HERV-Hs will require future studies to 
more comprehensively interrogate these HERV-Hs.
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Finally, our findings suggest the intriguing possibility that other ERV families of repeats 
and/or other families of repetitive elements may have similar abilities to create TADs and 
insulation. Thus, future studies of these repeat elements will be interesting to discover 
whether other distinct classes of repetitive elements may also exhibit similar capacity to 
influence chromatin architecture in a broad range of cell types that include not only PSCs 
but also more differentiated cell types. Because reactivation of various transposable elements 
has been implicated in mammalian aging, cancer and other diseases54–56, such future studies 
may also illuminate underlying mechanisms for how reactivation of these elements could 
contribute to disease by disrupting genome architecture and altering gene regulatory 
programs.
Methods
Cell culture, differentiation, and collections for large-scale cardiac molecular studies
For the large-scale genomic and transcriptomic human embryonic stem cell (hESC) cardiac 
studies (i.e. ChIP-seq, RNA-seq and HiC experiments), an engineered H9 hESC 
MLC2v:H2B-GFP reporter transgenic line, which specifically expresses H2B-GFP in 
differentiated ventricular cardiomyocytes (CMs), was used27. This H9 hESC MLC2v:H2B-
GFP line was differentiated into cardiomyocytes and their intermediate developmental stages 
utilizing a well-established Wnt-based cardiomyocyte differentiation protocol57 that we have 
previously used to efficiently create hESC-CMs58. Specifically, the following developmental 
cardiac cell populations were generated and collected: Day (D)0 (hESC), D2 (mesoderm), 
D5 (cardiac mesoderm), D7 (cardiac progenitors), D15 (primitive CMs) and D80 
(ventricular CMs). Differentiation efficiency was assessed at specific developmental cardiac 
stages by flow cytometry using antibodies against POU5F1 (Cell Signaling C30A3) - D0/
hESC, BRACHYURY/T (R&D Systems AF2085) - D2/mesoderm, KDR/PDGFRA (R&D 
Systems AF357P and AF1264A, respectively) - D5/cardiac mesoderm, cTnT (ThermoFisher 
MA5-12960) - D15/primitive CMs. Differentiation success for collected D2-D7 samples was 
further confirmed by re-plating a portion of the cells dissociated for collection and then 
maintaining them until ~D15 when CM differentiation could be assessed using cTnT flow 
analysis. Collected samples that resulted in high differentiation efficiency (> 90%) were then 
further processed and analyzed for molecular studies (see below). For D80 ventricular CMs, 
we additionally sorted and purified these cells based on MLC2v:H2B-GFP prior to their 
processing and analyses (Supplementary Fig. 1). For RNA-seq studies, ~2 million 
dissociated cells were washed in PBS, lysed in Trizol and then stored at −80 °C until further 
processing. For ChIP-seq studies, dissociated cells were washed in PBS, fixed in 1% 
formaldehyde for 10 min, quenched with 0.125 M Glycine for 5 min at room temperature 
(RT), then 10 min on ice and finally washed twice with PBS. These fixed cell pellets were 
then snap-frozen and stored at −80 °C until further processing.
In situ Hi-C
In situ Hi-C was performed as described previously with minor modifications10. Cells were 
harvested and pelleted by centrifugation at 300 g for 10 min. Cells were resuspended in PBS 
and fixed with 1% formaldehyde for 10 min at RT. The reaction was quenched by incubating 
with 125 mM glycine for 5 min at RT before transferring onto ice. Cells were pelleted (300 
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g for 10 min at 4 °C) and subsequently washed twice with ice-cold PBS. After the second 
wash concentration was adjusted to 2 million cells/ml and 1 ml was transferred to a 1.5 ml 
tube (Eppendorf). Cells were pelleted (1,000 g, 5 min at 4 °C). Following supernatant 
removal, the pellet was flash frozen in liquid nitrogen and stored at −80 °C. Nuclei were 
isolated using lysis buffer (10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 0.2% Igepal CA630) 
and incubation on ice for 15 min. Pelleted nuclei were permeabilized using 0.5% SDS and 
incubation for 10 min at 62 °C. SDS was quenched by adding Triton-X100. Chromatin was 
digested using the four base cutter restriction enzyme MboI (200 units, NEB) at 37 °C 
overnight. Digestion efficiency was checked by gel electrophoresis. After inactivation of 
MboI for 20 min at 62 °C, single-strand overhangs were filled with biotinylated-14-ATP 
(Life Technologies) using Klenow DNA polymerase (40 units, NEB) for 90 min at 37 °C. 
Next, DNA was ligated for 4 h at 16 °C using T4 ligase (2,000 units, NEB). Reverse 
crosslinking and protein degradation was performed using proteinase K (NEB) and 
incubation at 55 °C for 30 min. Finally, NaCl (500 mM) was added and the reaction was 
completed at 68 °C overnight. DNA was purified using ethanol precipitation and sonicated 
using an ultra sonicator (Covaris M220; duty cycle: 10; intensity: 4; cycles/burst: 220; 
duration: 55 s) to 300-700 bp small fragments. After size selection and purification using 
SPRI beads (Beckman Coulter), biotinylated DNA was isolated using Dynabeads MyOne T1 
Streptavidin beads (Life Technologies). Sequencing libraries were prepared on magnetic 
beads and final PCR amplification was carried out for 6 cycles. Size distribution of bead-
purified libraries was checked using a High Sensitivity D1000 ScreenTape on a Tapestation 
(Agilent) and quantified using Qubit (Life Technologies). Libraries were sequenced on 
Hiseq 4000 (100 bp PE, Illumina).
ChIP-seq
ChIP-seq experiments for all histone marks at all time points were performed as previously 
described59,60. The experiments were conducted according to experimental guidelines and 
read depth standards of the ENCODE consortium. Harvested cells were washed in PBS and 
fixed in 1% formaldehyde for 10 min at room temperature. Reaction was quenched with 125 
mM Glycine for 5 min at room temperature followed by 10 min incubation on ice. Next, the 
cells were washed twice with PBS. Crosslinked cells were lysed and chromatin sheared 
using a Branson Sonifier 450 (20 cycles, 15 sec ON, 45 sec OFF at power 3). Detailed 
protocols can be found on the ENCODE homepage for immunoprecipitation (https://
www.encodeproject.org/documents/89795b31-e65a-42ca-9d7bd75196f6f4b3/@@download/
attachment/Ren%20Lab%20ENCODE%20Chromatin%20Immunoprecipitation
%20Protocol_V2.pdf) and library preparation (https://www.encodeproject.org/documents/
4f73fbc3-956e-47ae-aa2d41a7df552c81/@@download/attachment/
Ren_ChIP_Library_Preparation_v060614.pdf). ChIP-seq experiments for CTCF and SMC3 
were carried out on two and ten million crosslinked cells, respectively, as previously 
described61,62. Nuclei were isolated using hypotonic buffer and subsequently lysed in RIPA 
buffer (140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1% sodium 
deoxycholate, 10 mM Tris-HCl pH 8.0 supplemented with protease inhibitor (Roche)) and 
chromatin was sheared using a Covaris M220. Cell lysates were precleared using Protein G 
beads (Sigma) and rotation for 3 h at 4 °C. For immunoprecipitation, chromatin was 
incubated with antibodies against CTCF overnight at 4 °C. Antibody chromatin complexes 
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were bound by Protein G beads for 2 h at 4 °C. After eight rounds of washing using 
combinations of high and low salt buffers, crosslinks were reversed with Proteinase K 
(NEB) at 65 °C overnight. DNA was purified by phenol/chloroform/isoamyl alcohol 
extraction and ethanol precipitation. Sequencing libraries were generated using the Accel-
NGS® 2S Plus DNA Library Kit (Swift). All ChIP-seq libraries were sequenced on HiSeq 
2500/4000 (50 bp SE, Illumina). Antibody information could be found in the “Life Sciences 
Reporting Summary”.
RNA-seq
Total RNA from cells was extracted using Trizol (Thermo) and purified with RNA Clean & 
Concentrator™−5 (R1013, Zymo Research). RNA sequencing libraries were prepared from 
1-2 µg total RNA using the Illumina TruSeq Stranded mRNA Library Prep Kit Set A 
(Illumina, RS-122-2101) or Set B (Illumina, RS-122-2102). Sequencing was carried out on 
HiSeq 2500/4000 (50/100 bp PE, Illumina).
HERV-H deletion study
To interrogate the functional significance of HERV-Hs, selected HERV-H sequences were 
genetically deleted in H9 MLC2v:H2B-GFP hESCs using CRISPR-Cas9 genome editing 
strategies. To this end, specific gRNA pairs with binding sites surrounding the target region 
were designed63 using a web-based software tool CRISPOR64, which generates gRNA 
sequences for optimal targeting of region of interest while minimizing potential off-target 
effects. These identified gRNAs were then synthesized in vitro using the GeneArt Precision 
gRNA Synthesis kit (Invitrogen). One day before transfection, 1 × 105 H9 MLC2v:H2B-
GFP hESCs were seeded in 12-well plates. When cells were 30-60% confluent, a pair of 
RNP complexes containing 2 µg of Cas9 protein (NEB) and 400 ng of in vitro transcribed 
gRNA were transfected using Lipofectamine Stem Transfection Reagent (Invitrogen)65,66. 
Three days after transfection, cells were diluted and clonally expanded for genotyping67. 
After confirmation of genome-edited clones by Sanger sequencing, at least two successfully 
targeted clones per deletion were selected for functional analysis. To examine the effects of 
deleting HERV-Hs on chromatin boundary formation and gene expression, in situ Hi-C and 
RNA-seq studies were respectively performed as described above. Because of the potential 
role of HERV-H1 in cardiac differentiation, HERV-H1-deleted H9 MLC2v:H2B-GFP hESC 
clones were additionally examined for their ability to differentiate into cardiomyocytes. To 
this end, hESC seeding density and canonical Wnt signaling levels were titrated to initially 
find suboptimal CM differentiation conditions that result in 50% CM differentiation by Day 
15 in control H9 MLC2v:H2B-GFP hESCs. These suboptimal CM differentiation conditions 
were then applied to both control and HERV-H1 deleted H9 MLC2v:H2B-GFP hESC clones 
to further assess their ability to differentiate into CMs from Day 7-15 as detected by TNNT2 
FACS analyses. The differentiation experiments were repeated three times.
HERV-H CRISPRi study
For the generation of the HERV-H1 or HERV-H2 CRISPRi lines, three CRISPRi gRNAs 
(Supplementary Table 5) were designed to target the DNA region from −50 to 300 bp 
relative to the TSS of the candidate genes68 and cloned into lenti-sgRNA (MS2)-puro 
plasmid (Addgene ID:73795)69. H9 MLC2v:H2B-GFP hESCs were firstly infected by 
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Lenti-dCas9-KRAB-blast virus (Addgene ID: 89567)70 and were selected by 5 μg/ml 
blasticidin for 5 days. Survivor cells were then transduced with gRNA lentivirus and 
selected by 1 μg/ml puromycin for 5 days. All cell lines were cultured for another 10 or 
more days to allow sufficient time for CRISPR inactivation of the target gene before being 
used for further experiments. HERV-H1 clone #3 and HERV-H2 clone #1 were selected for 
Hi-C and RNA-seq experiments based on their silencing efficacy and specificity.
HERV-H knock-in study
Plasmid construction—The PiggyBac expression vector PB-CMV-MCS-EF1α-
GreenPuro (System Biosciences, Cat. #PB513B-1) was modified to remove two core 
insulators and replace the original CMV promoter in the vector with EF1α promoter by 
Gibson assembly. Briefly, the EF1α-GreenPuro cassette and the backbone of PB-CMV-
MCS-EF1α-GreenPuro were PCR amplified respectively. Two fragments were then 
assembled together by NEBuilder HiFi DNA assembly master mix (NEB, Cat. #E2621S). 
The new modified plasmid was named as PB513Re.
To construct a HERV-H2 knock-in plasmid HERV-H2-PB513Re, an 8-kb sequence from the 
HERV-H2 locus (which includes 1 kb of additional sequences flanking of HERV-H2) was 
PCR-amplified and digested by Xho I and Not I, then cloned into PB513Re vector which 
was digested by the same two restriction enzymes. Recombined constructs were further 
verified by restriction enzyme digestion and sanger sequencing. The primers used for 
cloning were listed in Supplementary Table 5.
Generation of HERV-H2 knock-in line: To generate HERV-H2 knock-in line, we used 
PiggyBac transposon system which can efficiently integrate interested DNA into the genome 
at multiple sites71,72. One day before transfection, 1 × 105 HERV-H2-KO hESCs were 
seeded in 12-well plates. Next day, 1 μg HERV-H2-PB513Re plasmid and 0.1 μg transposase 
were transfected into the cells using Lipofectamine Stem Transfection Reagent. Cells were 
selected by 1 μg/ml puromycin for 5 days, then were diluted and clonally expanded for Hi-C 
and other further experiments. Two knock-in cell lines were obtained, named HERV-H-
ins.clone1 and HERV-H-ins.clone2, respectively.
Non-human primate iPSC cultures
Chimpanzee and bonobo iPSCs were cultured on plates pre-coated with Matrigel (BD 
Biosciences) in commercial mTeSR1™ medium (Stemcell technology, 85850). Cells were 
passaged every 5-6 days with TrypLE (Life Technologies) at a split ratio of 1:10. ROCK 
inhibitor Y27632 (10 µM) was added at least one hour prior to and 24 hours after passaging. 
Marmoset iPSCs were cultured on MEFs in CDF12 media containing DMEM/F12 (Life 
Technologies, 11330-032), 20% Knockout Serum Replacement (KSR, Life Technologies, 
10828), 2 mM Glutamax (Life Technolgies, 35050-061), 0,1 mM NEAA (Life Technologies, 
11140-050), 0.1 mM β-mercaptoethanol (Gibco, 21985) and 10 ng/ml FGF2 (Peprotech). 
Marmoset iPSCs were passaged every 6-7 days either using Collagenase IV (Life 
Technologies) at or TrypLE (Life Technologies) at 1:5 ratio. When passaged using TrypLE 
ROCK inhibitor Y27632 (10 µM) was added at least one hour prior to and 24 hours after 
passaging. Tests for mycoplasma contamination were routinely performed for all the cell 
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lines using PCR-based approach or MycoAlert mycoplasma detection kit (Lonza) following 
manufacturer’s recommendation every 10 passages.
ChIP-seq data processing
Read alignment: Reads were aligned to hg19 (GRC37) following standards of ENCODE 
ChIP-seq pipeline73. The full pipeline is available at https://github.com/ren-lab/chip-seq-
pipeline. Briefly, the reads were mapped with bwa74. PCR duplicates were removed using 
Picard75. Only reads with mapping quality > 30 were kept.
ChIP-seq peak calling: For each stage, ChIP-seq peaks were called using MACS276 for 
each biological replicate and pooled sample, using the pooled input sample as control. 
MACS2 was run with the default setting with “--nomodel –extsize 180” parameter. Peaks 
called in the pooled sample that also intersected with peaks in both replicates by at least 
50% bases were defined as replicated peaks and were used as the final peak list for that 
stage. Peaks from all stages were merged into a union peak list using bedtools mergeBed77.
ChIP-seq signal visualization: ChIP-seq bigWig files were generated using deeptools78 
bamCoverage function with the RPKM (Reads Per Kilobase of transcript per Million 
mapped reads) normalization option. Aggregated signal profiles were generated with the 
deeptools computeMatrix and plotProfile functions and further modified in R.
RNA-seq data processing:
Read alignment and quantification: RNA-seq alignment and quantification pipeline is 
available at https://github.com/ren-lab/rnaseq-pipeline. Briefly, reads were aligned to hg19 
(GRC37) and GENCODE GTF v19 with rnaSTAR79 following “ENCODE” options outlined 
in the rnaSTAR manual (http://labshare.cshl.edu/shares/gingeraslab/www-data/dobin/STAR/
STAR.posix/doc/STARmanual.pdf). PCR duplicates were removed using Picard. Raw reads 
for each gene were quantified using featureCounts80. Read per million reads and kilobases 
(RPKM) were calculated for each gene.
Differentiation gene expression analysis: differentially gene expression was 
performed using edgeR81 with the default normalization method, tagwise dispersion 
estimation function and glmLRT (negative binomial generalized log-linear model).
Hi-C data processing:
The HiC data processing pipeline is available at https://github.com/ren-lab/hic-pipeline. Hi-
C reads were aligned on hg19(GRC37) using BWA-MEM74 for each read separately, and 
then paired. For chimeric reads, only 5’ end mapped locations were kept. Duplicated read 
pairs mapped to the same location were removed to leave only one unique read pair. The 
output bam files were transformed into juicer file format and tag directories for further 
analysis in Juicebox 82 and HOMER83. Unless specified otherwise, we used the contact 
matrix in 10kb resolution and normalized using KR matrix balancing method.
Compartments A/B: Principal component analysis was performed using HOMER83 with 
resolution of 50 kb. DNA segments with positive PC1 value in both biological replicates 
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were defined as compartment A, whereas negative value for compartment B. Inconsistent 
PC1 signs between replicates were defined as inconsistent. For dynamic and static 
compartment analysis (Fig. 1b), only DNA segments with consistent compartment state at 
each of the six stages (which was 85% of all genomic bins) were included. A DNA segment 
was defined as static if it stayed compartment A or B at all six stages; Otherwise it was 
named dynamic. Compartment switch types were defined as “BA” if it switched from B to 
A, and vice versa. If the compartment bin switched from A to B, and then switched back to 
A, it will be defined as “ABA”, and the same rule applies to “BAB”. Bins with more than 2 
switches were very rare and left out in the analysis/plot. Hierarchical clustering was 
performed on the PC1 values of all dynamic bins, by both rows (segments) and columns 
(sample replicates), using (1- Pearson correlation coefficient) as distance and average 
linkage method to merge branches.
Insulation score: To quantify insulation based on KR normalized contact frequencies we 
used the insulation score defined in Crane et al. 2015 29, using 500 kb as the square size, and 
200 kb as the delta size. Insulation TADs were called using the perl script at https://
github.com/dekkerlab/crane-nature-2015.
Directionality Index: We calculated the Directionality Index (DI) as described in Dixon et 
al.5. The KR normalized contact matrices were used as input to this transformation. We 
generated the DI score at two different resolutions: 10 kb and 40 kb. In both cases, we 
limited the scope of interaction to 2 Mb upstream or downstream.
Topologically associating domains (TADs)
TAD identification: We called TADs using three different algorithms: domain caller5, 
Arrowhead10 and insulation score29. All methods were run with the default parameters 
recommended in the user manual and with the resolution at 10 kb. They produced different 
number of TADs because of inherent difference in their algorithms and choice of default 
parameters. Nevertheless, the same trend of TAD loss was observed (Supplementary Fig. 
4a,b,c).
Identification of non-redundant TAD boundaries: TAD boundaries were previously 
found to be conserved between cell types8. Based on this assumption, we should be able to 
find a set of non-redundant TAD boundaries across different cell types. To identify non-
redundant boundaries across all samples, we collapsed spatially identical or close TADs 
across all time points and replicates. To do this, we first quantile normalized the 
Directionality Index (DI) scores genome-wide between all twelve samples. Then we 
calculated the DI delta scores for each TAD boundary. DI delta score is the average 
difference in DI between the 4 bins (10 kb per bin) downstream and 4 bins upstream of the 
boundary. We concatenated TAD boundaries from all samples (twelve) and sorted them by 
their DI delta scores in descending order. Then we picked one TAD boundary from the top 
of the list and remove any remaining boundary within 50 kb of the top TAD boundary. The 
number as well as the stages of removed boundaries are recorded in the kept TAD 
boundaries as two additional columns. Then we picked the next TAD boundary on the list 
and repeat the same process, until the entire list was traversed. To remove unwanted spurious 
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calls, any TAD boundary without a redundant (duplicate) call is discarded. For each non-
redundant TAD boundary, it is denoted as a boundary (TRUE) in a stage if the DI delta score 
is greater than 200 in both replicates in that stage, otherwise is FALSE.
Dynamic TAD boundaries across stages: To determine dynamic TAD boundaries 
across stages, we first obtained the DI delta scores for each non-redundant TAD boundary. 
Then we log transformed the score and used the values as input to LIMMA84. LIMMA 
package was used to call differential boundary strength between each adjacent stage 
comparisons (e.g. D00 vs D02, D02 vs D05, etc.). P values were calculated with the eBayes 
function within LIMMA with trend parameter disabled, and were adjusted using Benjamini-
Hochberg method. A TAD boundary was called dynamic if its adjusted P value was less than 
0.01 in any adjacent stage comparisons. Otherwise, it was called a stable TAD boundary. 
However, if the delta scores of that boundary were consistently greater than 200 in all 
samples, regardless of its state called in LIMMA, it was denoted as stable TAD boundary. 
Within dynamic TAD boundaries, we denoted the ones that were only present (TRUE) at 
D00 as ESC(+) TAD boundaries, those that were only FALSE at D80 as vCM(−) TAD 
boundaries (Fig. 1c).
Overlap of TAD and TAD boundaries with CTCF and repeat elements: Overlap 
of CTCF ChIP-seq peaks and repeat elements to TAD and/or TAD boundaries were 
performed using BEDtools intersect77. When performing intersections, the TAD boundaries 
were increased to ± 25 kb from the original TAD boundaries to account for algorithmic 
inaccuracies in calling boundaries. Repeat elements were RepeatMasker annotation 
downloaded directly from UCSC85. To avoid spurious results introduced by repeats with few 
copies in the genome, only repeats with more than 1,000 copies genome-wide were tested 
here. The intersections were performed against each repeat name category separately, and 
for ESC(+) TADs, vCM(−) TADs and all stable TADs. For each repeat element, we obtained 
the fraction of TAD boundaries that contained that repeat. Then we calculated the fold 
enrichment of each repeat element at the TAD boundaries of ESC(+) (or vCM(−) ) TADs 
over stable TAD boundaries. The significance of the enrichment was computed using two-
sided proportion test function in R. The repeat elements with fold enrichment greater than 
two and P value less than 0.01 were reported as significantly enriched.
Gene expression profile at the TAD boundaries containing repeat elements 
(Fig. 2a and Supplementary Fig. 5a): For each of the eight repeat elements found in 
Figure 1c, we kept the DNA sequences that intersected with ESC(+) TAD boundaries. Using 
these sequences as reference point, we generated the average RPKM normalized signal over 
± 50 kb of the reference point with deeptools computeMatrix function78. Only LTR7 and 
HERVH-int sequences displayed high expression in hESCs.
HERV-H related analysis
Contact matrix on HERV-Hs transcribed at different levels (Fig. 2c,d): To 
investigate the boundary activity of HERV-Hs that transcribed at different levels, we 
visualized the contact matrix at 10-kb resolution. We sorted the HERV-H loci by their 
expression RPKMs in hESCs (day 0) in descending order and assign every 50 loci to a bin. 
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For each bin, we generated the median observed/expected score of each interacting pixel 200 
kb surrounding the HERV-H loci. The same obs/exp matrix were computed at day 2 and day 
5 for top 50 loci, and for rank51-100 and rank101-150 loci at day 0.
Directionality index profile on HERV-Hs in iPSCs and H1-derived cells and on 
all genes transcribed at different levels. (relating to Supplementary Fig. 
6a,b): The Hi-C data for human iPSCs were from Greenwald et al38. The Hi-C data from 
H1 ESC and its derived cells were from Dixon et al5,8. The data were downloaded and 
processed the same way as described above. Because DI scores are dependent on the 
sequencing depth, the H1ESC DI profile may look less pronounced comparing to the iPSC.
To investigate whether the correlation of gene expression and boundary strength also holds 
true for all genes, we also plotted DI score profile for human genes that express at different 
levels. We first sort the genes by their RPKMs in the hESC from high to low, and then group 
every 1,000 genes into bins, and further separate them into groups with CTCF peaks within 
20 kb of TSSs or not. Aggregated median DI scores were plotted for each group of genes at 
10-kb resolution up to 200 kb.
ChIP-seq enrichment analysis at TAD boundary-associating HERV-H loci 
(relating to Supplementary Fig. 8): To investigate which protein(s) may be responsible 
for TAD boundary formation at top 50 transcribing HERV-H loci, we downloaded hESC 
ChIP-seq bigWig files from ENCODE (primary) and other sources in the public domain 
(prefixed with the SRA ID if downloaded from other than ENCODE)86. For each ChIP-seq 
data, we computed the average bigWig signal on the top 50 HERV-Hs with 
bigWigAverageOverBed command from UCSC, and the average bigWig signal on HERV-Hs 
ranking from 51 to 300. Then we calculated the fold change with these two averages.
HERV-H insertion analysis (relating to Fig. 5 and Supplementary Figure 11): To 
identify the loci of HERV-H2 insertion, we extracted discordant read pairs from Hi-C that 
had one end mapped to the HERV-H2 DNA sequence. Based on Hi-C’s proximity ligation 
principle, we expect to see pileup of reads at genomic locations where the HERV-H2 were 
inserted into. Based on a naïve algorithm to detect clusters of adjacent 10-kb bins with more 
than 30 read pileups, we uncovered 33 and 19 insertions in HERV-H-ins.clone1 and HERV-
H-ins.clone2, respectively. We further narrowed the number of reliable insertions sites for 
analysis to 43 total insertions by choosing insertions that had RNA-seq signal from the 
widespread readthrough transcription at insertion sites. Directionality Index (DI) scores were 
calculated as described in Methods section (Hi-C data processing: Directionality Index) with 
a window size of 10 kb for the HERV-H-ins.clone1 HERV-H-ins.clone2 and HERV-H2-KO 
(parental) Hi-C data. Delta DI scores were calculated by finding the absolute difference 
between the average of 2 DI scores immediately upstream of the insertion bin and 2 DI 
scores immediately downstream of the insertion bin.
HERV-H insertion allelic analysis (relating to Fig. 5c,d): Reads from Hi-C of all 
developmental stages were used for genotyping and haplotype phasing. First, variants were 
called according to the GATK best practice pipeline87 using GATK 3.6-017-19. Briefly, 
reads were realigned, and base pair qualities were recalibrated. Variants were then called 
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using HaplotypeCaller (GATK) with default parameters. Variants were then recalibrated 
based on known gold standard variants. Only variants that passed filters were used in the 
downstream analysis. Considering possible artifact caused by restricted enzyme ligation, 
variants within MboI sites were removed. Second, high quality (quality > 30) heterozygous 
bi-allelic SNPs were phased using HaploSeq pipeline88. Briefly, reads from Hi-C data were 
extracted using extractHAIRs and then used as input for HAPCUT289 to generate 
haplotypes.
Haplotype phasing was performed on the HERV-H2-KO, HERV-H-ins.clone1, and HERV-H-
ins.clone2 Hi-C bam files using the obtained haplotype-phased VCF files. This created two 
bam files corresponding to “allele A” and “allele B” for each input bam file. In order to 
determine which phased allele contained each insertion, we calculated the number of 
discordant read pairs with one end mapping to HERV-H2 and the other end mapping to each 
predicted insertion position (within 100 kb). The phased bam with the most HERV-H 
discordant read pairs mapping to it was labeled as the KI allele in each case. Each phased 
bam file was converted to a pgl file using pgltools90 samTopgl to facilitate insulation 
analysis. We defined the “cross-over contact score” as the number of interactions that cross a 
10-kb bin divided by the number of interactions upstream and downstream of the bin, within 
a 200-kb window. The “cross-over contact score” measures the level of chromatin contact 
insulation. Cross-over contact scores were calculated in this manner for all insertion 
positions in the unaffected alleles as well as the predicted KI alleles. Two insertions (at 
chr2:213896052 and chr1:49135920) were removed from analysis because they contained 
bins where there were no interactions that crossed the bin, leading to 0 scores and bins 
where all interactions crossed the bin, leading to infinite scores. The R heatmap.2 function 
from gplots was used to plot the heatmap of the row Z-score normalized cross-over contact 
scores for the KI alleles and the unaffected alleles for each insertion position (Fig. 5d).
HERV-H comparative analysis (relating to Fig. 6): Mouse ESC Hi-C data from 
Bonev et al.23 was downloaded from SRA and aligned to mm10 with the same procedure as 
described above. Bonobo, chimpanzee and marmoset iPSC Hi-C data were aligned to 
panPan2, panTro6 and calJac3 reference genome, respectively, with the same procedure. The 
syntenic regions in mouse, marmoset, chimpanzee and bonobo to the human HERV-H loci 
(± 20 kb centered on each HERV-H sequence) were obtained using UCSC liftover tool with 
minimum ratio of base remap of 0.1.
HERV-H LTR type and divergence analysis (relating to Supplementary. Fig. 
12): To investigate the sequence features of the LTRs flanking TAD boundary associated 
HERV-Hs and non-boundary associated HERV-Hs, we examined their presence, length and 
sequence divergence. The LTRs for HERV-H include LTR7, LTR7A, LTR7B, LTR7C and 
LTR7Y. We downloaded the annotations for those LTRs from repeatMasker and assigned 
them to each HERV-H-int sequence by base overlap. The HERV-H loci were ordered by 
their expression levels and binned as described above (the top 50 were enriched at TAD 
boundaries).
Sequence divergence between the 5’ LTR and 3’LTR sequences was used to measure the 
insertion time for retrotransposons. Based on the retrotransposon insertion mechanism, at the 
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time of insertion, 5’ and 3’ LTR sequences should be identical; the LTR sequences will each 
accumulate mutations over time, and thus their sequence differences could be used as a 
proxy to their ages. We followed the steps outlined in https://github.com/SIWLab/Lab_Info/
wiki/Ageing-LTR-insertions to align each LTR pairs and calculated the sequence 
divergences91,92.
General data processing and plots
Most of the described data processing steps (statistical tests, clustering, plotting, etc.) were 
performed in python 3.4.5 (www.python.org) and statistical computing environment R 3.4.3 
(www.r-project.org). Boxplots were made with ggplot2 (https://cran.r-project.org/web/
packages/ggplot2). The elements of the boxplot are: center line, median; box limit, upper 
and lower quartiles; whiskers, 1.5× interquartile range; points, outliers.
Data availability
All sequencing datasets have been deposited on GEO with the accession number 
GSE116862.
Code availability
Scripts are available at https://github.com/shawnzhangyx/cvdc_scripts.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reorganization of TADs during human cardiomyocyte differentiation.
(a) Hi-C contact matrices for each stage of cardiomyocyte differentiation at mega-base 
resolution. (b) A heatmap showing hierarchical clustering of dynamic chromatin 
compartments during cardiomyocyte differentiation. The pseudo-color reflects the PC1 
values (compartment A/B) of compartment bins. Negative PC1 value stands for 
compartment B and positive for compartment A. Representative genes located in 
corresponding compartment bins are annotated to the right of the heatmap. (c) A heatmap 
showing the DI delta scores for the stage-specific TAD boundaries, ordered by the presence 
of TADs at six stages. vCM(−) stands for TAD boundaries lost in purified ventricular 
cardiomyocytes at D80, ESC(+) stands for hESC-specific TAD boundaries. (d) Scatter plot 
shows the fold enrichment and −log10(P values) for various repeat element classes at ESC(+) 
(N = 198) and vCM(−) (N = 329) TAD boundaries relative to the static TAD boundaries (N 
= 2,622). P values are from two-sided proportion test.
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Figure 2. Transcriptionally active HERV-H forms human ESC-specific TAD boundaries.
(a) Aggregated RNA-seq expression profile (RPKM normalized) at ESC(+) TAD boundaries 
that overlap HERV-H element. (b) Scatterplot shows the expression levels (RPKM) across 
different HERV-H loci (ordered by expression levels from high to low in ESC) at D0, D2 
and D5 stages of differentiation. (c) Heatmap of aggregated Hi-C contact matrix 
[log2(observed/expected)] within 200 kb of the top 50, 51-100 and 101-150 ranked HERV-
Hs, at D0. (d) Heatmap of the aggregated Hi-C matrix [log2(observed/expected)] within 200 
kb of the top 50 HERV-Hs, at D0, D2 and D5. (e,f) Representative Hi-C interaction matrices 
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of two HERV-H loci located at ESC(+) TAD boundaries at D0, D2 and D5 (top) are shown 
as heatmaps along with genome browser tracks of POLR2A, SMC3, CTCF, H3K27ac ChIP-
seq and RNA-seq data of the expanded genomic region containing the TAD boundary 
(arrow). (g) Aggregated genomic profiles of RNA-seq, POLR2A, SMC3 and CTCF ChIP-
seq around top 50 HERV-Hs located on the ESC(+) TAD boundaries (red) and lower ranked 
HERV-Hs (grey).
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Figure 3. Deletion of two HERV-H sequences leads to merging of TADs in hESCs.
(a) Hi-C interaction matrices of the wild-type (WT) and transgenic hESC lines (HERV-H1-
KO and HERV-H2-KO) are shown, along with DI scores, expression levels (RPKM) and 
fold changes of gene expression at the HERV-H1 and HERV-H2 loci. The loss of TAD 
boundary in the transgenic cells is accompanied with decrease of RNA expression of genes 
5’ terminus to the HERV-H sequences. (b) Boxplots show expression levels (RPKMs) of 
genes whose TSSs are located from −500 kb to the 5’ LTR (N = 49) and from 3’ LTR to 
+500 kb (N = 49) of boundary-associated HERV-Hs. P values are from two-sided paired t 
test on the log-transformed expression levels. The elements of the boxplot are: center line, 
median; box limit, upper and lower quartiles; whiskers, 1.5× interquartile range. (c) Line 
chart (mean ± standard error, N = 3 cardiomyocyte differentiations) shows percentage of 
TNNT2 positive cells during cardiomyocyte differentiation of WT and HERV-H1-KO hESC 
lines (two HERV-H1-KO clones analyzed). HERV-H1-KO hESCs display increased 
cardiomyocyte differentiation efficiency compared to WT hESCs.
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Figure 4. Silencing of HERV-H sequences weakened the TAD boundaries in hESC.
(a) Design of the CRISPR-dCas9-KRAB system to silence HERV-H expression using 
sgRNAs targeting 5’ LTR7. (b) Gene expression values of HERV-H1 and HERV-H2 in WT 
and CRISPRi-targeted hESCs. (c) Hi-C interaction matrices of the CRISPRi targeted hESC 
lines (sgHERV-H1 and sgHERV-H2) are shown, along with DI scores, and log2(fold-change) 
of gene expression in engineered cell lines over control at the HERV-H1 and HERV-H2 loci.
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Figure 5. HERV-H insertion creates de novo TAD boundaries.
(a) Design of the piggybac vector to “transpose” HERV-H to random genomic locations in 
the hESC (HERV-H2-KO line). (b) Hi-C contact matrices of the parental cell line (HERV-
H2-KO) and the cell line with HERV-H insertions (HERV-H-ins.clone1) are shown, along 
with DI scores at the locus of one HERV-H insertion. (c) Line plots showing the cross-over 
contact scores of both alleles in parental cell line (HERV-H2-KO) and HERV-H-ins.clone1 at 
the same locus as in (b). Only the allele (B) harboring HERV-H insertion shows a decrease 
of cross-over contact score (increase of insulation). (d) Heatmap shows the z-transformed 
cross-over contact scores for all predicted knock-in (KI) alleles and unaffected alleles in the 
HERV-H inserted cells.
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Figure 6. HERV-H introduces new TAD boundaries during primate evolution.
(a) A simplified tree of primate evolution with the copies of HERV-H annotated (left) and 
Hi-C interaction matrices of human ESCs, bonobo iPSCs, chimpanzee iPSCs, marmoset 
iPSCs and mouse ESCs are shown, along with DI scores at the syntenic regions to human 
HERV-H1 locus, HERV-H2 locus, and all top 50 transcribing HERV-Hs. The chimpanzee 
and bonobo syntenic regions are denoted with a star as they also contain HERV-H sequence. 
(b) Bar chart shows the percentage of HERV-H transcripts over all transcripts in the PSCs 
from each indicated species.
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